To prepare aripiprazole long-acting injectable suspension and study its pharmacokinetics in rabbits. Suspension was prepared by high-pressure homogenization and the product was obtained after freeze-drying; The concentration of drug in plasma was determined by high performance liquid chromatography. The long-acting injectable suspension formulation obtained was uniform and stable in particle size and had no significant irritation to animal tissues. The in vivo pharmacokinetics results showed that the long-acting injection has a good sustained-release effect in vivo and can be sustainedly released for 15 days. Aripiprazole long-acting injectable suspension have controllable quality and can be released continuously and steadily, which is expected to provide a convenient, safe and effective new dosage form for schizophrenic patients.
LI Xin
,
LIU Haofan
,
YANG Han
,
ZHAO Na
,
ZHANG Donghao
,
HU Liandong
. Preparation and pharmacokinetics of aripiprazole long-acting injectable suspension[J]. Journal of Hebei University(Natural Science Edition), 2018
, 38(6)
: 610
-616
.
DOI: 10.3969/j.issn.1000-1565.2018.06.009
[1] 周雨林.阿立哌唑对精神分裂症患者生活质量的影响[J]. 中国民康医学,2007,19(10):354.DOI:10.3969/j.issn.1672-0369.2007.10.020. ZHOU Y L. The analysis of treatment schizophrenia by aripiprazole and olanzapine[J]. Medical Journal of Chinese People’s Health, 2007,19(10):354. DOI:10.3969/j.issn.1672-0369.2007.10.020.
[2] 吴仁容,李乐华. 新型抗精神病药:阿立哌唑[J]. 国外医学:精神病学分册,2004(3):177-179. DOI:10.13479/j.cnki.jip.2004.03.017.
[3] PATEL N C, CRISMON M. Aripiprazole: A comprehensive review of its pharmacology, clinical efficacy,and tolerability[J]. Clinical Therapeutics,2004,26(5): 649-666.DOI:10.1016/S0149-2918(04)90066-5.
[4] FERNáNDEZ M L, BAÑO R D, BARBERO G E, et al. Qualitative study of patients with dual pathology in treatment with aripiprazole extended-release injectable suspension[J]. European Psychiatry,2016,33. DOI:10.1016/j.eurpsy.2016.01.1043.
[5] 胡宗伟. ZL004长效注射剂的制备及评价[D]. 中国医药工业研究总院,2016. HU Z W. The preparation and evaluation of ZL004 long-acting injections[D]. China Stata Institute of Pharmaceutica Industry, 2016.
[6] 朱建芬,吴祥根.纳米混悬剂的制备方法及在药剂学中应用的研究进展[J]. 中国医药工业杂志,2006(03):196-200. DOI:10.3969/j.issn.1001-8255.2006.03.021. ZHU J F, WU X G. Progress of the preparation and applications in pharmaceutics of nanosuspensions[J]. Chinese Journal of Pharmaceuticals, 2006(03):196-200. DOI:10.3969/j.issn.1001-8255.2006.03.021.
[7] 谢向阳,陈晨,廖祥茹.纳米混悬剂的物理稳定性研究进展[J].国际药学研究杂志,2011,38(05):369-374. DOI:10.13220/j.cnki.jipr.2011.05.014. XIE X Y, CHEN C, LIAO X R. Physical stability of nanosuspensions:research advances[J]. International Journal of Pharmaceutical Research, 2011,38(05):369-374. DOI:10.13220/j.cnki.jipr.2011.05.014.
[8] WILLIAM W L, JOHANNES P, MICHAEL W,et al. A brief literature and patent review of nanosuspensions to a final drug product[J]. Journal of Pharmaceutical Sciences, 2014,103(10). DOI:10.1002/jps.24098.
[9] 鲍玉,林贵梅,栾玉霞.纳米混悬液的制备方法及其在药物输送中应用的研究进展[J]. 药物生物技术,2011,18(04):364-368. DOI:10.19526/j.cnki.1005-8915.2011.04.021. BAO Y, LIN G H, LUAN Y X. Advances in study on the preparation of nanosuspensions and the application of drug delivery[J]. Pharmaceutical Biotechnology, 2011,18(04):364-368. DOI:10.19526/j.cnki.1005-8915.2011.04.021.
[10] 鲁龙,毕生雷,金洪波.高压匀质法破碎小球藻细胞工艺优化[J]. 食品工业科技,2017,38(06):304-307+349. DOI:10.13386/j.issn1002-0306.2017.06.049. LU L, BI S L, JIN H B. Optimization of chlorella cell disruption process by high pressure homogenization [J]. Science and Technology of Food Industry, 2017,38(6):304-307+349. DOI:10.13386/j.issn1002-0306.2017.06.049.
[11] BERNARD V E,GUY V D,PATRICK A. Top-down production of drug nanocrystals: Nanosuspension stabilization, miniaturization and transformation into solid products[J]. International Journal of Pharmaceutics,2008,364(1). DOI:10.1016/j.ijpharm.2008.07.023. DOI:10.14146/j.cnki.cjp.2015.06.001.
[12] 钟月,何璐瑛,王艳娇. 反溶剂结合湿法研磨技术制备阿立哌唑混悬注射剂[J]. 中 国 药 剂 学 杂 志:网络版, 2015,13(06):189-195. DOI:10.14146/j.cnki.cjp.2015.06.001. ZHONG Y HE L Y,WANG Y J. A combined anti-solvent/wet ball milling approach to prepare aripiprazole injectable suspension[J].Chinese Journal of Pharmaceutics,2015,13(06):189-195.DOI: 10.14146/j.cnki.cjp.2015.06.001.
